Product Name: Travoprost CAS NO: 157283-68-6
(+)-Fluprostenol isopropyl ester;
Chemical & Physical Properties:
Appearance: colorless oil
Boiling point: 584.8℃ at 760 mmHg
Travoprost is a new type of PG drug developed by Alcon Pharmaceuticals, USA. It is an analogue of PGF2α. It has high selectivity and affinity for PGFP receptor. It is a complete agonist. The US Food and Drug Administration (FDA) approved a PG drug for the treatment of primary open-angle glaucoma and ocular hypertension in September 2006.
Travoprost ophthalmic solution is a topical medication used for controlling the progression of glaucoma or ocular hypertension, by reducing intraocular pressure. It is a synthetic prostaglandin analog (or more specifically, an analog of prostaglandin F2α) that works by increasing the outflow of aqueous fluid from the eyes.
We can also provide Travoprost CAS 157283-68-6 related intermediate:
2. CAS NO: 1373876-51-7
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.